{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:13:50Z","timestamp":1781108030024,"version":"3.54.1"},"reference-count":25,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.3960\/jslrt.22037","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T22:11:02Z","timestamp":1672179062000},"page":"273-278","source":"Crossref","is-referenced-by-count":2,"title":["Lymphoplasmacytic lymphoma with IgG-\u03ba paraproteinemia presenting as a hepatic bulky mass"],"prefix":"10.3960","volume":"62","author":[{"given":"Masakazu","family":"Higuchi","sequence":"first","affiliation":[{"name":"Department of Hematology, Kyushu Railway Memorial Hospital, Kitakyushu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takemasa","family":"Senoo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyushu Railway Memorial Hospital, Kitakyushu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Kyushu Railway Memorial Hospital, Kitakyushu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Furugo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kyushu Railway Memorial Hospital, Kitakyushu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine & Surgical Pathology, Kyushu Railway Memorial Hospital, Kitakyushu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Treon SP, Xu L, Yang G <i>et al.<\/i> MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia. N Engl J Med. 2012; 367: 826-833.","DOI":"10.1056\/NEJMoa1200710"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Gachard N, Parrens M, Soubeyran I <i>et al.<\/i> IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphomas. Leukemia. 2013; 27: 183-189.","DOI":"10.1038\/leu.2012.257"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Poulain S, Roumier C, Decambron A <i>et al.<\/i> MYD88 L265P mutation in Waldenstr\u00f6m macroglobulinemia. Blood. 2013; 121: 4504-4511.","DOI":"10.1182\/blood-2012-06-436329"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Castillo JJ, Itchaki G, Gustine JN <i>et al.<\/i> A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinemia. Leuk Lymphoma. 2020; 61: 1388-1394.","DOI":"10.1080\/10428194.2020.1719100"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Cao X, Medeiros LJ, Xia Y <i>et al.<\/i> Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression. Leuk Lymphoma. 2016; 57: 1104-1113.","DOI":"10.3109\/10428194.2015.1096357"},{"key":"6","unstructured":"6 Borgonovo G, d\u2019Oiron R, Amato A <i>et al.<\/i> Primary lymphoplasmacytic lymphoma of the liver associated with a serum monoclonal peak of IgG kappa. Am J Gastroenterol. 1995; 90: 137-140."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Treon SP, Cao Y, Xu L <i>et al.<\/i> Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstr\u00f6m macroglobulinemia. Blood. 2014; 123: 2791-2796.","DOI":"10.1182\/blood-2014-01-550905"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Owen RG, Kyle RA, Stone MJ <i>et al.<\/i> Response assessment in Waldenstr\u00f6m macroglobulinaemia: update from the VIth International Workshop. Br J Haematol. 2013; 160: 171-176.","DOI":"10.1111\/bjh.12102"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ghobrial IM. Are you sure this is Waldenstr\u00f6m macroglobulinemia? Hematology (Am Soc Hematol Educ Program). 2012; 2012: 586-594.","DOI":"10.1182\/asheducation.V2012.1.586.3798562"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Dimopoulos MA, Kastritis E. How I treat Waldenstr\u00f6m macroglobulinemia. Blood. 2019; 134: 2022-2035.","DOI":"10.1182\/blood.2019000725"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Yu X, Li W, Deng Q <i>et al.<\/i> MYD88 L265P Mutation in Lymphoid Malignancies. Cancer Res. 2018; 78: 2457-2462.","DOI":"10.1158\/0008-5472.CAN-18-0215"},{"key":"12","unstructured":"12 Swerdlow SH, Harris NL, Cook JR, et al. Lymphoplasmacytic lymphoma. In : Swerdlow SH, Campo E, Harris NL, <i>et al.<\/i> (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, IARC Press. 2017; pp. 232-235."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 King RL, Gonsalves WI, Ansell SM <i>et al.<\/i> Lymphoplasmacytic lymphoma with a non-IgM paraprotein shows clinical and pathologic heterogeneity and may harbor MYD88 L265P mutations. Am J Clin Pathol. 2016; 145: 843-851.","DOI":"10.1093\/ajcp\/aqw072"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Varettoni M, Boveri E, Zibellini S <i>et al.<\/i> Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network. Am J Hematol. 2019; 94: 1193-1199.","DOI":"10.1002\/ajh.25600"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Robillard N, Avet-Loiseau H, Garand R <i>et al.<\/i> CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. Blood. 2003; 102: 1070-1071.","DOI":"10.1182\/blood-2002-11-3333"},{"key":"16","unstructured":"16 Haji S, Abe Y, Tsuda M <i>et al.<\/i> [CD20-positive plasma cell myeloma with lymphoplasmacytoid appearance mimicking low-grade B-cell lymphoma]. Rinsho Ketsueki. 2015; 56: 335-338 [in Japanese]."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Heerema-McKenney A, Waldron J, Hughes S <i>et al.<\/i> Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma. Am J Clin Pathol. 2010; 133: 265-270.","DOI":"10.1309\/AJCPUS3PRRT5ZXVS"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Nagata S, Harimoto N, Kajiyama K. Primary hepatic mucosa-associated lymphoid tissue lymphoma: a case report and literature review. Surg Case Rep. 2015; 1: 87.","DOI":"10.1186\/s40792-015-0091-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Dong S, Chen L, Chen Y, Chen X. Primary hepatic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type: A case report and literature review. Medicine (Baltimore). 2017; 96: e6305.","DOI":"10.1097\/MD.0000000000006305"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Falini B, Agostinelli C, Bigerna B <i>et al.<\/i> IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. Histopathology. 2012; 61: 930-941.","DOI":"10.1111\/j.1365-2559.2012.04289.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Buske C, Hoster E, Dreyling M <i>et al.<\/i> The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG). Leukemia. 2009; 23: 153-161.","DOI":"10.1038\/leu.2008.261"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Dimopoulos MA, Anagnostopoulos A, Kyrtsonis MC <i>et al.<\/i> Primary treatment of Waldenstr\u00f6m macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide. J Clin Oncol. 2007; 25: 3344-3349.","DOI":"10.1200\/JCO.2007.10.9926"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Rummel MJ, Niederle N, Maschmeyer G <i>et al.<\/i> Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet. 2013; 381: 1203-1210.","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Treon SP, Ioakimidis L, Soumerai JD <i>et al.<\/i> Primary therapy of Waldenstr\u00f6m macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180. J Clin Oncol. 2009; 27: 3830-3835.","DOI":"10.1200\/JCO.2008.20.4677"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Dimopoulos MA, Tedeschi A, Trotman J <i>et al.<\/i> Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstr\u00f6m\u2019s Macroglobulinemia. N Engl J Med. 2018; 378: 2399-2410.","DOI":"10.1056\/NEJMoa1802917"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/4\/62_22037\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T04:55:24Z","timestamp":1672462524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/4\/62_22037\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.22037","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"22037"}}